Skip to main content

Treatment Clinical Trials for Endometrial Cancer

Review the endometrial cancer treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 76-100 of 130

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Status: Active
Location: 3 locations
Avelumab with M1774 for the Treatment of Patients with ARID1A-Mutated Recurrent Endometrial Cancer who have Received Prior Immunotherapy
Status: Active
Location: 2 locations
Azenosertib for the Treatment of Women with Recurrent or Persistent Uterine Serous Carcinoma
Status: Active
Location: 2 locations
Afatinib in Treating Patients with Recurrent Stage I-IV HER2 Positive Uterine Cancer
Status: Active
Location: 2 locations
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Status: Active
Location: 2 locations
At-Home Cancer Directed Therapy versus in Clinic for the Treatment of Patients with Advanced Cancer, Cancer CARE Beyond Walls
Status: Active
Location: 2 locations
A Study of GSK5733584 in Combination With Anti-cancer Therapies for Advanced Solid Tumors
Status: Active
Location: 4 locations
Study of AVZO-021 in Patients With Advanced Solid Tumors
Status: Active
Location: 7 locations
A Beta-only IL-2 ImmunoTherapY Study
Status: Active
Location: 2 locations
Frontline Immunotherapy Combined with Radiation and Chemotherapy in High Risk Endometrial Cancer, FIERCE Study
Status: Active
Location: 2 locations
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Status: Active
Location: 2 locations
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Status: Active
Location: 2 locations
Comparison of Acute Toxicities between Patients Treated with Protons or Intensity Modulated Radiation Therapy after Surgery for the Treatment of Endometrial or Cervical Cancer
Status: Active
Location: 2 locations
Selective Surgical Staging versus Reflex Lymphadenectomy in Evaluating Sentinel Lymph Nodes in Non-mappers Undergoing Surgery for Endometrial Cancer
Status: Active
Location: University of Kentucky/Markey Cancer Center, Lexington, Kentucky
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Status: Active
Location: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia
Reiki Therapy to Improve Symptoms Associated with Brachytherapy in Patients with Gynecological Malignancies, Reiki-Brachy Trial
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Glucagon-Like Peptide 1 Receptor Agonists in Combination with a Levonorgestrel Intrauterine Device for the Treatment of Patients with Obesity and Early Stage Uterine Cancer
Status: Active
Location: UF Health Cancer Institute - Gainesville, Gainesville, Florida
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Guarana for Fatigue in Patients with Neuroendocrine Tumors and Early Stage Gynecologic Cancers
Status: Active
Location: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Status: Active
Location: 2 locations
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Status: Active
Location: 3 locations
Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
Status: Active
Location: 4 locations
E7777 and Pembrolizumab for the Treatment of Patients with Recurrent or Metastatic Cancer
Status: Active
Location: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania